ERNA: A newer neurophysiological biomarker to automate DBS programming
Shownotes
In this episode, Dr. Mitra Afshari speaks with Dr. Jen Nagao about her latest work highlighting the automation of subthalamic deep brain stimulation (DBS) with Evoked Resonant Neural Activity (ERNA) in Parkinson’s disease. They discuss the potential benefits of ERNA over beta power in the operating room and future opportunities to explore this newer neurophysiological marker for DBS programming. Read the article. Journal CME is available until June 30, 2027.